4//SEC Filing
TARRIFF SCOTT L 4
Accession 0001082504-05-000002
CIK 0000878088other
Filed
Jan 9, 7:00 PM ET
Accepted
Jan 10, 3:43 PM ET
Size
8.8 KB
Accession
0001082504-05-000002
Insider Transaction Report
Form 4
TARRIFF SCOTT L
DirectorPresident & CEO
Transactions
- Award
Restricted Stock
2005-01-06+21,062→ 21,062 total - Award
Common Stock, Option to Buy
2005-01-06+47,845→ 47,845 totalExercise: $42.14Exp: 2015-01-06→ Common Stock (47,845 underlying)
Holdings
- 118,600
Common Stock
- 1,500(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]85,000 shares of Common Stock are subject to a forward sales contract entered into on December 2, 2003 by Mr. Tarriff, which was previously reported on Form 4 filed with the Securities & Exchange Commission on December 4, 2003.
- [F2]25% vest on the first anniversary of the date of grant and an additional 25% vest on each anniversary thereafter.
Documents
Issuer
PAR PHARMACEUTICAL COMPANIES, INC.
CIK 0000878088
Entity typeother
Related Parties
1- filerCIK 0001192853
Filing Metadata
- Form type
- 4
- Filed
- Jan 9, 7:00 PM ET
- Accepted
- Jan 10, 3:43 PM ET
- Size
- 8.8 KB